跳转至内容
Merck

860693P

Avanti

C24:0 Ceramide (d18:2(4E,8Z)/24:0)

Avanti Research - A Croda Brand 860693P, powder

别名:

N-lignoceroyl-D-erythro-sphingosine (d18:2(4E,8Z) base)

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C42H81NO3
分子量:
648.10
分類程式碼代碼:
12352211
NACRES:
NA.25

形狀

powder

包裝

pkg of 1 × 1 mg (860693P-1mg)

製造商/商標名

Avanti Research - A Croda Brand 860693P

脂質類型

sphingolipids

運輸包裝

dry ice

儲存溫度

−20°C

SMILES 字串

OC[C@@](NC(CCCCCCCCCCCCCCCCCCCCCCC)=O)([H])[C@]([H])(O)/C=C/CC/C=C\CCCCCCCCC

一般說明

C24:0 Ceramide (d18:2(4E,8Z)/24:0), also known as N-lignoceroyl-D-erythro-sphingosine (d18:2(4E,8Z) base), is a very long chain plasma ceramide derived from sphingosine containing two double bonds with lignoceric acid.

生化/生理作用

Altered levels of C24:0 Ceramide has been observed in mild cognitive impairment (MCI) patients. It acts as a primary biomarker of Alzheimer disease (AD) progression.

包裝

5 mL Amber Glass Screw Cap Vial (860693P-1mg)

法律資訊

Avanti Research is a trademark of Avanti Polar Lipids, LLC

也與該產品經常一起購買

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

No data available

閃點(°C)

No data available


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Michelle M Mielke et al.
Alzheimer's & dementia : the journal of the Alzheimer's Association, 6(5), 378-385 (2010-09-04)
A blood-based biomarker of Alzheimer's disease (AD) would be superior to cerebrospinal fluid (CSF) and neuroimaging measures in terms of cost, invasiveness, and feasibility for repeated measures. We previously reported that blood ceramides varied in relation to timing of memory

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门